Skip to main content icon/video/no-internet

Informed consent (IC) is a fundamental legal and ethical tenet that requires three conditions for any valid intervention (diagnostic, therapeutic, preventive, or related to research): That the participant (1) is provided with sufficient information to make an informed choice, (2) gives consent voluntarily, and (3) is competent to make a decision about involvement. Strictly speaking, requiring IC implies that no intervention or data gathering should take place until a potential participant has been informed about the purpose, nature, risks, and benefits of the intervention, and having acquired an adequate understanding of what the intervention entails has freely consented to it.

IC is predicated on the fundamental ethical principles of respect, beneficence (having the welfare of the participant as a goal), and nonmalfeasance (avoiding harm to the participant) as reflected in the protection of personal autonomy and privacy and defined variously in legal codes of nation states. Changes in decision-making capacity throughout the life span determine an individual’s ability for autonomous decision-making and have prompted regulations to enable treatment and research with persons in health-care settings who lack sufficient capacity.

The explicit recognition of respect for autonomy is reflected in the general turning away from the use of the term subject and the widespread adoption of the preferred term participant. This entry provides an overview of legal codes related to voluntary consent and then describes information disclosure and confidentiality, voluntariness, and competence in the consent process.

The first international document to require voluntary consent for research participation was the Nuremberg Code (1947). This instrument aimed to prevent experiments such as the ones performed on nonconsenting concentration camp prisoners during World War II from happening again and to extend the principle of requiring freely given consent to all forms of intervention.

Other important research ethics guidelines followed. Examples include the World Medical Association Declaration of Helsinki (adopted in 1964 and last amended in 2013) and the Council for International Organizations of Medical Sciences International Ethical Guidelines for Biomedical Research involving Human Subjects (2002). Guidelines were also issued by professional and research institutions in a number of countries such as the Belmont Report (1979) in the United States, the Tri-Council Policy Statement (2014) in Canada, and the Economic and Social Research Council Framework for Research Ethics in the United Kingdom (introduced in 2006).

Information Disclosure and Confidentiality

IC requires that sufficient information be provided to participants that their decision can be based on a good understanding of burden, risks, and potential benefits to self and others and that they express their consent to the intervention. A consequence of defining consent in this way is that the provision of information is not in itself sufficient, although necessary. The inclusion of a requirement of capacity to decide, in particular, has led to a recognition of valid consent as a broader, more inclusive appropriate term. To obtain valid consent, in general, information needs to be provided about the following:

  • The nature, extent, and duration of the procedures involved, including risks and benefits related to the involvement in a project and the broader public interest.
  • Arrangements to mitigate and respond to adverse events.
  • Measures to ensure privacy and the protection of confidentiality of personal information.
  • Rights to withdraw at any time without prejudice and within specified limits to the destruction of information.

Both the information provided and the language used need to be adapted to the particular situation of the patients or research participants, adapted to their emotional and cognitive abilities to understand the nature and consequences of the intervention and to make consequent decisions. Thus, information should be provided in lay terms and in accessible formats. If new relevant information emerges that might modify any of the bases on which the consent decision has been made, it should be immediately shared with patients or research participants. It is important during the consent process and the duration of the intervention that providers and researchers make themselves available to answer participants’ questions openly and honestly.

...

  • Loading...
locked icon

Sign in to access this content

Get a 30 day FREE TRIAL

  • Watch videos from a variety of sources bringing classroom topics to life
  • Read modern, diverse business cases
  • Explore hundreds of books and reference titles

Sage Recommends

We found other relevant content for you on other Sage platforms.

Loading